Skip to main content
. Author manuscript; available in PMC: 2014 Apr 1.
Published in final edited form as: Hepatology. 2013 Apr;57(4):1325–1332. doi: 10.1002/hep.26246

Figure 2. Barriers to HCV Treatment.

Figure 2

A. Barriers by Global region: mean (SD) Likert response to each of 31 potential barriers, by region.

B. Regional Barriers by Category: mean (SD) Likert response to each barrier category, by region.

US, United States; CAN, Canada; LAT, Latin America; WE, Western Europe; CEE, Central/Eastern Europe; NOR, Nordic; AP, Asia/Pacific; MEA, Middle East/Africa

*Each barrier rated on a 10-point Likert scale, from 0 “not a barrier” to 10 “large barrier.”